Deoxyribonucleic acid-based electron selective contact for crystalline silicon solar cells

Development of carrier selective contacts for crystalline silicon solar cells has been recently of great interest towards the further expansion of silicon photovoltaics. The use of new electron and hole selective layers has opened an array of possibilities due to the low-cost processing and non-dopi...

Full description

Bibliographic Details
Authors: Tom, Thomas, Ros Costals, Eloi, Rovira, David, López Vidrier, Julià, Asensi López, José Miguel, Ortega Villasclaras, Pablo Rafael, Puigdollers i González, Joaquim, Voz Sánchez, Cristóbal, Bertomeu i Balagueró, Joan
Format: article
Status:Published version
Publication Date:2022
Country:España
Institution:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repository:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/191622
Online Access:https://hdl.handle.net/2445/191622
Access Level:Open access
Keyword:ADN
Interfícies (Ciències físiques)
Cèl·lules solars
DNA
Interfaces (Physical sciences)
Solar cells
Description
Summary:Development of carrier selective contacts for crystalline silicon solar cells has been recently of great interest towards the further expansion of silicon photovoltaics. The use of new electron and hole selective layers has opened an array of possibilities due to the low-cost processing and non-doping contacts. Here, a non-doped heterojunction silicon solar cell without the use of any intrinsic amorphous silicon is fabricated using Deoxyribonucleic acid (DNA) as the electron transport layer (ETL) and transition metal V<sub>2</sub>O<sub>5</sub> as the hole transport layer (HTL). The deposition and characterization of the DNA films on crystalline silicon have been studied, the films have shown a n -type behaviour with a work function of 3.42 eV and a contact resistance of 28 mΩ cm<sup>2</sup>. This non-doped architecture has demonstrated a power conversion efficiency of 15.5%, which supposes an increase of more than 9% with respect to the cell not containing the biomolecule, thus paving the way for a future role of nucleic acids as ETLs.